Modified stem cells tested as new weapon against spreading kidney cancer
Disease control
Terminated
This early-phase study tested a one-time treatment called Temferon for patients with advanced kidney cancer that had spread and stopped responding to standard therapies. Temferon uses a patient's own modified stem cells, designed to produce a cancer-fighting protein (interferon) …
Phase: PHASE1, PHASE2 • Sponsor: Genenta Science • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC